IV, Alteplase
Loading...
References
- Craig S Anderson. Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferiority trial.. Lancet (London, England), 2025
- Charles B Majoie. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials.. Lancet (London, England), 2023
- Katherine T. Mun. Fragility Index Meta-Analysis of Randomized Controlled Trials Shows Highly Robust Evidential Strength for Benefit of <3 Hour Intravenous Alteplase. Stroke, 2022
- S. Mendelson. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review.. JAMA, 2021
- G. Thomalla. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.. Lancet, 2020
- Pengfei Yang. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke.. The New England journal of medicine, 2020
- B. Campbell. Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. The Lancet, 2019
- A. Kelly. Guideline: The AHA/ASA made 217 recommendations for early management of acute ischemic stroke in adults. Annals of Internal Medicine, 2018
- Lucas McCarthy. Pooled RCTs: In patients with acute ischemic stroke, alteplase increases intracerebral hemorrhage. Annals of Internal Medicine, 2016
- William N Whiteley. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.. The Lancet. Neurology, 2016
- Jonathan Emberson. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.. Lancet (London, England), 2014
- Joanna M Wardlaw. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.. Lancet (London, England), 2012